Home › Companies › SUMMIT THERAPEUTICS INC. › 2024-2025
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and SUMMIT THERAPEUTICS INC.’s Form 8-K, filed June 17, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 12, 2025: 11 items on SUMMIT THERAPEUTICS INC.’s Form 8-K, filed June 17, 2025: 11 passed (calculated).
No notable dissent.
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore SUMMIT THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are SUMMIT THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 17, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Robert W. Duggan | 613,045,226 | -- | -- | 26,692 | 29,651,787 | 99.9% | Passed (calculated) | — |
| Elect Director: Mahkam Zanganeh | 613,581,910 | -- | -- | 37,546 | 29,651,787 | 99.9% | Passed (calculated) | — |
| Elect Director: Manmeet Soni | 611,431,814 | -- | -- | 52,326 | 29,651,787 | 99.9% | Passed (calculated) | — |
| Elect Director: Kenneth A. Clark | 605,079,891 | -- | -- | 51,558 | 29,651,787 | 99.9% | Passed (calculated) | — |
| Elect Director: Robert Booth | 623,298,472 | -- | -- | 55,319 | 29,651,787 | 99.9% | Passed (calculated) | — |
| Elect Director: Alessandra Cesano | 617,638,155 | -- | -- | 54,443 | 29,651,787 | 99.9% | Passed (calculated) | — |
| Elect Director: Yu (Michelle) Xia | 610,437,122 | -- | -- | 54,396 | 29,651,787 | 99.9% | Passed (calculated) | — |
| Elect Director: Mostafa Ronaghi | 620,904,380 | -- | -- | 54,324 | 29,651,787 | 99.9% | Passed (calculated) | — |
| Elect Director: Jeff Huber | 623,664,686 | -- | -- | 53,330 | 29,651,787 | 99.9% | Passed (calculated) | — |
| Ratification of the appointment of PricewaterhouseCoopers LLP | 653,328,708 | 195,007 | 233,629 | -- | -- | 99.9% | Passed (calculated) | — |
| Advisory vote to approve the compensation of named executive officers | 607,320,353 | 16,607,648 | 177,556 | -- | 29,651,787 | 97% | Passed (calculated) | — |
Source: SUMMIT THERAPEUTICS INC., Form 8-K, filed with the SEC on June 17, 2025 — read the filing on EDGAR.
See voting trends for Health Care companies, 2024-2025: shareholder support by sector and by company size.
227 asset managers disclosed a vote on at least one SUMMIT THERAPEUTICS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Prior year: 98.8% for (June 14, 2024 meeting) ▲ 1.2 pts
Description as filed by funds: ELECTION OF DIRECTORS: Alessandra Cesano
SUMMIT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Alessandra Cesano”): 617,638,155 for, 54,443 withheld, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 60 asset managers below reported 9,918,109 for, 4,534,823 against, 3,840 abstained, 72 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 4,400,670 | 0 | 0 | 0 | For |
| Vanguard | 803 | 3,701,082 | 0 | 0 | Against |
| Fidelity | 1,300,395 | 0 | 0 | 0 | For |
| Charles Schwab | 1,250,341 | 0 | 0 | 0 | For |
| Aberdeen | 1,200,810 | 0 | 0 | 0 | For |
| BlackRock | 0 | 725,530 | 0 | 0 | Against |
| State Street | 228,828 | 65 | 0 | 0 | For |
| Lincoln Financial | 223,736 | 0 | 0 | 0 | For |
| Putnam | 169,673 | 0 | 0 | 0 | For |
| Equitable | 100,627 | 14,710 | 0 | 0 | Mixed |
| Russell Investments | 106,900 | 0 | 0 | 0 | For |
| Tema ETF Trust | 99,215 | 0 | 0 | 0 | For |
| John Hancock | 87,503 | 0 | 0 | 0 | For |
| Calamos | 72,844 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 70,417 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 67,441 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 61,722 | 0 | 0 | 0 | For |
| AQR | 60,815 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 60,789 | 0 | 0 | 0 | For |
| ProShares | 50,750 | 0 | 0 | 0 | For |
| TIAA | 47,790 | 0 | 0 | 0 | For |
| Northern Trust | 42,563 | 0 | 0 | 0 | For |
| JPMorgan | 31,802 | 0 | 0 | 0 | For |
| Pacific Life | 0 | 30,452 | 0 | 0 | Against |
| Global X | 23,834 | 0 | 0 | 0 | For |
Showing the 25 largest of 60 asset managers. All 60 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Description as filed by funds: ELECTION OF DIRECTORS: Jeff Huber
SUMMIT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Jeff Huber”): 623,664,686 for, 53,330 withheld, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 60 asset managers below reported 14,429,752 for, 23,180 against, 3,840 abstained, 72 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 4,400,670 | 0 | 0 | 0 | For |
| Vanguard | 3,701,117 | 768 | 0 | 0 | For |
| Fidelity | 1,300,395 | 0 | 0 | 0 | For |
| Charles Schwab | 1,250,341 | 0 | 0 | 0 | For |
| Aberdeen | 1,200,810 | 0 | 0 | 0 | For |
| BlackRock | 725,530 | 0 | 0 | 0 | For |
| State Street | 228,828 | 65 | 0 | 0 | For |
| Lincoln Financial | 223,736 | 0 | 0 | 0 | For |
| Putnam | 169,673 | 0 | 0 | 0 | For |
| Equitable | 115,337 | 0 | 0 | 0 | For |
| Russell Investments | 106,900 | 0 | 0 | 0 | For |
| Tema ETF Trust | 99,215 | 0 | 0 | 0 | For |
| John Hancock | 87,503 | 0 | 0 | 0 | For |
| Calamos | 72,844 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 70,417 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 67,441 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 61,722 | 0 | 0 | 0 | For |
| AQR | 60,815 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 60,789 | 0 | 0 | 0 | For |
| ProShares | 50,750 | 0 | 0 | 0 | For |
| TIAA | 47,790 | 0 | 0 | 0 | For |
| Northern Trust | 42,563 | 0 | 0 | 0 | For |
| JPMorgan | 31,802 | 0 | 0 | 0 | For |
| Pacific Life | 30,452 | 0 | 0 | 0 | For |
| Global X | 23,834 | 0 | 0 | 0 | For |
Showing the 25 largest of 60 asset managers. All 60 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Prior year: 98.6% for (June 14, 2024 meeting) ▲ 1.3 pts
Description as filed by funds: ELECTION OF DIRECTORS: Kenneth A. Clark
SUMMIT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Kenneth A. Clark”): 605,079,891 for, 51,558 withheld, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 60 asset managers below reported 4,750,781 for, 9,702,150 against, 3,840 abstained, 72 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 0 | 4,400,670 | 0 | 0 | Against |
| Vanguard | 3,701,117 | 768 | 0 | 0 | For |
| Fidelity | 66,372 | 1,234,023 | 0 | 0 | Mixed |
| Charles Schwab | 453 | 1,249,888 | 0 | 0 | Against |
| Aberdeen | 0 | 1,200,810 | 0 | 0 | Against |
| BlackRock | 422,891 | 302,639 | 0 | 0 | Mixed |
| State Street | 642 | 228,251 | 0 | 0 | Against |
| Lincoln Financial | 0 | 223,736 | 0 | 0 | Against |
| Putnam | 169,673 | 0 | 0 | 0 | For |
| Equitable | 14,710 | 100,627 | 0 | 0 | Mixed |
| Russell Investments | 0 | 106,900 | 0 | 0 | Against |
| Tema ETF Trust | 99,215 | 0 | 0 | 0 | For |
| John Hancock | 0 | 87,503 | 0 | 0 | Against |
| Calamos | 72,844 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 70,417 | 0 | 0 | Against |
| OPTIMUM FUND TRUST | 0 | 67,441 | 0 | 0 | Against |
| Principal Exchange-Traded Funds | 0 | 61,722 | 0 | 0 | Against |
| AQR | 0 | 60,815 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 60,789 | 0 | 0 | Against |
| ProShares | 0 | 50,750 | 0 | 0 | Against |
| TIAA | 47,790 | 0 | 0 | 0 | For |
| Northern Trust | 42,563 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 31,802 | 0 | 0 | Against |
| Pacific Life | 30,452 | 0 | 0 | 0 | For |
| Global X | 0 | 23,834 | 0 | 0 | Against |
Showing the 25 largest of 60 asset managers. All 60 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Prior year: 100.0% for (June 14, 2024 meeting) unchanged
Description as filed by funds: ELECTION OF DIRECTORS: Mahkam Zanganeh
SUMMIT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Mahkam Zanganeh”): 613,581,910 for, 37,546 withheld, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 60 asset managers below reported 9,318,420 for, 5,134,512 against, 3,840 abstained, 72 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 0 | 4,400,670 | 0 | 0 | Against |
| Vanguard | 3,701,885 | 0 | 0 | 0 | For |
| Fidelity | 1,300,395 | 0 | 0 | 0 | For |
| Charles Schwab | 1,250,341 | 0 | 0 | 0 | For |
| Aberdeen | 1,200,810 | 0 | 0 | 0 | For |
| BlackRock | 725,530 | 0 | 0 | 0 | For |
| State Street | 228,605 | 288 | 0 | 0 | For |
| Lincoln Financial | 67,900 | 155,836 | 0 | 0 | Mixed |
| Putnam | 169,673 | 0 | 0 | 0 | For |
| Equitable | 107,440 | 7,897 | 0 | 0 | Mixed |
| Russell Investments | 106,900 | 0 | 0 | 0 | For |
| Tema ETF Trust | 99,215 | 0 | 0 | 0 | For |
| John Hancock | 0 | 87,503 | 0 | 0 | Against |
| Calamos | 72,844 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 70,417 | 0 | 0 | Against |
| OPTIMUM FUND TRUST | 0 | 67,441 | 0 | 0 | Against |
| Principal Exchange-Traded Funds | 0 | 61,722 | 0 | 0 | Against |
| AQR | 0 | 60,815 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 60,789 | 0 | 0 | Against |
| ProShares | 0 | 50,750 | 0 | 0 | Against |
| TIAA | 47,790 | 0 | 0 | 0 | For |
| Northern Trust | 42,563 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 31,802 | 0 | 0 | Against |
| Pacific Life | 30,452 | 0 | 0 | 0 | For |
| Global X | 23,834 | 0 | 0 | 0 | For |
Showing the 25 largest of 60 asset managers. All 60 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Description as filed by funds: ELECTION OF DIRECTORS: Manmeet S. Soni
SUMMIT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Manmeet Soni”): 611,431,814 for, 52,326 withheld, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 60 asset managers below reported 8,963,239 for, 5,489,693 against, 3,840 abstained, 72 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 0 | 4,400,670 | 0 | 0 | Against |
| Vanguard | 3,701,117 | 768 | 0 | 0 | For |
| Fidelity | 1,300,395 | 0 | 0 | 0 | For |
| Charles Schwab | 1,250,201 | 139 | 0 | 0 | For |
| Aberdeen | 1,200,810 | 0 | 0 | 0 | For |
| BlackRock | 725,530 | 0 | 0 | 0 | For |
| State Street | 642 | 228,251 | 0 | 0 | Against |
| Lincoln Financial | 0 | 223,736 | 0 | 0 | Against |
| Putnam | 169,673 | 0 | 0 | 0 | For |
| Equitable | 107,440 | 7,897 | 0 | 0 | Mixed |
| Russell Investments | 106,900 | 0 | 0 | 0 | For |
| Tema ETF Trust | 99,215 | 0 | 0 | 0 | For |
| John Hancock | 0 | 87,503 | 0 | 0 | Against |
| Calamos | 72,844 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 70,417 | 0 | 0 | Against |
| OPTIMUM FUND TRUST | 0 | 67,441 | 0 | 0 | Against |
| Principal Exchange-Traded Funds | 0 | 61,722 | 0 | 0 | Against |
| AQR | 0 | 60,815 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 60,789 | 0 | 0 | Against |
| ProShares | 0 | 50,750 | 0 | 0 | Against |
| TIAA | 47,790 | 0 | 0 | 0 | For |
| Northern Trust | 42,563 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 31,802 | 0 | 0 | Against |
| Pacific Life | 30,452 | 0 | 0 | 0 | For |
| Global X | 0 | 23,834 | 0 | 0 | Against |
Showing the 25 largest of 60 asset managers. All 60 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Prior year: 99.7% for (June 14, 2024 meeting) ▲ 0.3 pts
Description as filed by funds: ELECTION OF DIRECTORS: Mostafa Ronaghi
SUMMIT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Mostafa Ronaghi”): 620,904,380 for, 54,324 withheld, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 60 asset managers below reported 13,195,729 for, 1,257,203 against, 3,840 abstained, 72 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 4,400,670 | 0 | 0 | 0 | For |
| Vanguard | 3,701,117 | 768 | 0 | 0 | For |
| Fidelity | 66,372 | 1,234,023 | 0 | 0 | Mixed |
| Charles Schwab | 1,250,341 | 0 | 0 | 0 | For |
| Aberdeen | 1,200,810 | 0 | 0 | 0 | For |
| BlackRock | 725,530 | 0 | 0 | 0 | For |
| State Street | 228,828 | 65 | 0 | 0 | For |
| Lincoln Financial | 223,736 | 0 | 0 | 0 | For |
| Putnam | 169,673 | 0 | 0 | 0 | For |
| Equitable | 115,337 | 0 | 0 | 0 | For |
| Russell Investments | 106,900 | 0 | 0 | 0 | For |
| Tema ETF Trust | 99,215 | 0 | 0 | 0 | For |
| John Hancock | 87,503 | 0 | 0 | 0 | For |
| Calamos | 72,844 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 70,417 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 67,441 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 61,722 | 0 | 0 | 0 | For |
| AQR | 60,815 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 60,789 | 0 | 0 | 0 | For |
| ProShares | 50,750 | 0 | 0 | 0 | For |
| TIAA | 47,790 | 0 | 0 | 0 | For |
| Northern Trust | 42,563 | 0 | 0 | 0 | For |
| JPMorgan | 31,802 | 0 | 0 | 0 | For |
| Pacific Life | 30,452 | 0 | 0 | 0 | For |
| Global X | 23,834 | 0 | 0 | 0 | For |
Showing the 25 largest of 60 asset managers. All 60 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Prior year: 99.9% for (June 14, 2024 meeting) unchanged
Description as filed by funds: ELECTION OF DIRECTORS: Robert Booth
SUMMIT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Robert Booth”): 623,298,472 for, 55,319 withheld, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 60 asset managers below reported 14,427,092 for, 25,840 against, 3,840 abstained, 72 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 4,400,670 | 0 | 0 | 0 | For |
| Vanguard | 3,701,117 | 768 | 0 | 0 | For |
| Fidelity | 1,300,395 | 0 | 0 | 0 | For |
| Charles Schwab | 1,250,341 | 0 | 0 | 0 | For |
| Aberdeen | 1,200,810 | 0 | 0 | 0 | For |
| BlackRock | 725,530 | 0 | 0 | 0 | For |
| State Street | 228,828 | 65 | 0 | 0 | For |
| Lincoln Financial | 223,736 | 0 | 0 | 0 | For |
| Putnam | 169,673 | 0 | 0 | 0 | For |
| Equitable | 115,337 | 0 | 0 | 0 | For |
| Russell Investments | 106,900 | 0 | 0 | 0 | For |
| Tema ETF Trust | 99,215 | 0 | 0 | 0 | For |
| John Hancock | 87,503 | 0 | 0 | 0 | For |
| Calamos | 72,844 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 70,417 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 67,441 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 61,722 | 0 | 0 | 0 | For |
| AQR | 60,815 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 60,789 | 0 | 0 | 0 | For |
| ProShares | 50,750 | 0 | 0 | 0 | For |
| TIAA | 47,790 | 0 | 0 | 0 | For |
| Northern Trust | 42,563 | 0 | 0 | 0 | For |
| JPMorgan | 31,802 | 0 | 0 | 0 | For |
| Pacific Life | 30,452 | 0 | 0 | 0 | For |
| Global X | 23,834 | 0 | 0 | 0 | For |
Showing the 25 largest of 60 asset managers. All 60 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Prior year: 99.9% for (June 14, 2024 meeting) ▲ 0.1 pts
Description as filed by funds: ELECTION OF DIRECTORS: Robert W. Duggan
SUMMIT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Robert W. Duggan”): 613,045,226 for, 26,692 withheld, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 60 asset managers below reported 9,301,747 for, 5,151,185 against, 3,840 abstained, 72 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 0 | 4,400,670 | 0 | 0 | Against |
| Vanguard | 3,701,885 | 0 | 0 | 0 | For |
| Fidelity | 1,300,395 | 0 | 0 | 0 | For |
| Charles Schwab | 1,250,341 | 0 | 0 | 0 | For |
| Aberdeen | 1,200,810 | 0 | 0 | 0 | For |
| BlackRock | 725,530 | 0 | 0 | 0 | For |
| State Street | 228,605 | 288 | 0 | 0 | For |
| Lincoln Financial | 67,900 | 155,836 | 0 | 0 | Mixed |
| Putnam | 169,673 | 0 | 0 | 0 | For |
| Equitable | 107,440 | 7,897 | 0 | 0 | Mixed |
| Russell Investments | 106,900 | 0 | 0 | 0 | For |
| Tema ETF Trust | 99,215 | 0 | 0 | 0 | For |
| John Hancock | 0 | 87,503 | 0 | 0 | Against |
| Calamos | 72,844 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 70,417 | 0 | 0 | Against |
| OPTIMUM FUND TRUST | 0 | 67,441 | 0 | 0 | Against |
| Principal Exchange-Traded Funds | 0 | 61,722 | 0 | 0 | Against |
| AQR | 0 | 60,815 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 60,789 | 0 | 0 | Against |
| ProShares | 0 | 50,750 | 0 | 0 | Against |
| TIAA | 47,790 | 0 | 0 | 0 | For |
| Northern Trust | 42,563 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 31,802 | 0 | 0 | Against |
| Pacific Life | 30,452 | 0 | 0 | 0 | For |
| Global X | 23,834 | 0 | 0 | 0 | For |
Showing the 25 largest of 60 asset managers. All 60 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Prior year: 99.9% for (June 14, 2024 meeting) ▲ 0.1 pts
Description as filed by funds: ELECTION OF DIRECTORS: Yu (Michelle) Xia
SUMMIT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Yu (Michelle) Xia”): 610,437,122 for, 54,396 withheld, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 60 asset managers below reported 7,800,244 for, 6,652,688 against, 3,840 abstained, 72 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 0 | 4,400,670 | 0 | 0 | Against |
| Vanguard | 3,701,885 | 0 | 0 | 0 | For |
| Fidelity | 1,300,395 | 0 | 0 | 0 | For |
| Charles Schwab | 1,250,341 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 1,200,810 | 0 | 0 | Against |
| BlackRock | 725,530 | 0 | 0 | 0 | For |
| State Street | 642 | 228,251 | 0 | 0 | Against |
| Lincoln Financial | 0 | 223,736 | 0 | 0 | Against |
| Putnam | 169,673 | 0 | 0 | 0 | For |
| Equitable | 107,440 | 7,897 | 0 | 0 | Mixed |
| Russell Investments | 106,900 | 0 | 0 | 0 | For |
| Tema ETF Trust | 99,215 | 0 | 0 | 0 | For |
| John Hancock | 0 | 87,503 | 0 | 0 | Against |
| Calamos | 72,844 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 70,417 | 0 | 0 | Against |
| OPTIMUM FUND TRUST | 0 | 67,441 | 0 | 0 | Against |
| Principal Exchange-Traded Funds | 0 | 61,722 | 0 | 0 | Against |
| AQR | 0 | 60,815 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 60,789 | 0 | 0 | Against |
| ProShares | 0 | 50,750 | 0 | 0 | Against |
| TIAA | 47,790 | 0 | 0 | 0 | For |
| Northern Trust | 42,563 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 31,802 | 0 | 0 | Against |
| Pacific Life | 30,452 | 0 | 0 | 0 | For |
| Global X | 23,834 | 0 | 0 | 0 | For |
Showing the 25 largest of 60 asset managers. All 60 are in the interactive database (link above).
Combines 11 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Prior year: 97.4% for (June 14, 2024 meeting) ▼ 0.1 pts
Description as filed by funds: Approval, by a non-binding advisory vote, of the compensation of our named executive officers.
SUMMIT THERAPEUTICS INC.’s own tally for this item (“Advisory vote to approve the compensation of named executive officers”): 607,320,353 for, 16,607,648 against, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 0 | 4,400,670 | 0 | 0 | Against |
| Vanguard | 3,701,117 | 768 | 0 | 0 | For |
| Fidelity | 66,372 | 1,234,023 | 0 | 0 | Mixed |
| Charles Schwab | 1,250,341 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 1,200,810 | 0 | 0 | Against |
| BlackRock | 725,530 | 0 | 0 | 0 | For |
| State Street | 228,605 | 288 | 0 | 0 | For |
| Lincoln Financial | 67,900 | 155,836 | 0 | 0 | Mixed |
| Putnam | 0 | 169,673 | 0 | 0 | Against |
| Equitable | 14,710 | 100,627 | 0 | 0 | Mixed |
| Russell Investments | 106,900 | 0 | 0 | 0 | For |
| Tema ETF Trust | 99,215 | 0 | 0 | 0 | For |
| John Hancock | 0 | 87,503 | 0 | 0 | Against |
| Calamos | 72,844 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 70,417 | 0 | 0 | Against |
| OPTIMUM FUND TRUST | 0 | 67,441 | 0 | 0 | Against |
| Principal Exchange-Traded Funds | 0 | 61,722 | 0 | 0 | Against |
| AQR | 0 | 60,815 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 60,789 | 0 | 0 | Against |
| ProShares | 0 | 50,750 | 0 | 0 | Against |
| TIAA | 47,790 | 0 | 0 | 0 | For |
| Northern Trust | 42,563 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 31,802 | 0 | 0 | Against |
| Pacific Life | 30,452 | 0 | 0 | 0 | For |
| Global X | 23,834 | 0 | 0 | 0 | For |
Fund voting reports, all 59 managers: 6,551,445 for, 7,892,269 against, 3,840 abstained, 72 not voted. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 0 | 5,375,687 | 0 | 0 | Against |
| Fidelity | 0 | 2,748,279 | 0 | 0 | Against |
| PICTET ASSET MANAGEMENT SA | 0 | 2,324,786 | 0 | 0 | Against |
| Charles Schwab | 1,251,506 | 0 | 0 | 0 | For |
| State Street | 1,238,576 | 6,975 | 0 | 0 | For |
| Aberdeen | 0 | 1,200,810 | 0 | 0 | Against |
| BlackRock | 1,107,276 | 33,892 | 0 | 0 | For |
| ROCKLAND TRUST CO | 800,000 | 0 | 0 | 0 | For |
| Rock Springs Capital Management LP | 0 | 570,994 | 0 | 0 | Against |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 464,135 | 0 | 0 | 0 | For |
| Northern Trust | 430,049 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 271,962 | 0 | 0 | Against |
| Putnam | 0 | 246,973 | 0 | 0 | Against |
| Point72 | 0 | 235,502 | 0 | 0 | Against |
| Ensign Peak Advisors, Inc | 220,733 | 0 | 0 | 0 | For |
| Allianz | 0 | 211,625 | 0 | 0 | Against |
| Russell Investments | 208,008 | 0 | 0 | 0 | For |
| Citadel | 189,507 | 0 | 0 | 0 | For |
| BANK OF AMERICA NA | 184,640 | 0 | 0 | 0 | For |
| BANK OF MONTREAL /CAN/ | 856 | 179,414 | 0 | 0 | Against |
| PRINCIPAL GLOBAL INVESTORS | 0 | 171,289 | 0 | 0 | Against |
| Vanguard | 162,969 | 4,531 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 0 | 148,574 | 0 | 0 | Against |
| BALYASNY ASSET MANAGEMENT L.P. | 123,465 | 0 | 0 | 0 | For |
| GRIFFIN ASSET MANAGEMENT, INC. | 0 | 118,442 | 0 | 0 | Against |
Institutional-manager reports, all 182 managers: 7,035,929 for, 14,821,431 against, 23 abstained, 262 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Description as filed by funds: Ratification of the appointment of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2025.
SUMMIT THERAPEUTICS INC.’s own tally for this item (“Ratification of the appointment of PricewaterhouseCoopers LLP”): 653,328,708 for, 195,007 against, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 59 asset managers below reported 14,449,105 for, 478 against, 3,840 abstained, 72 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 4,400,670 | 0 | 0 | 0 | For |
| Vanguard | 3,701,885 | 0 | 0 | 0 | For |
| Fidelity | 1,300,395 | 0 | 0 | 0 | For |
| Charles Schwab | 1,250,341 | 0 | 0 | 0 | For |
| Aberdeen | 1,200,810 | 0 | 0 | 0 | For |
| BlackRock | 725,530 | 0 | 0 | 0 | For |
| State Street | 228,893 | 0 | 0 | 0 | For |
| Lincoln Financial | 223,736 | 0 | 0 | 0 | For |
| Putnam | 169,673 | 0 | 0 | 0 | For |
| Equitable | 115,337 | 0 | 0 | 0 | For |
| Russell Investments | 106,900 | 0 | 0 | 0 | For |
| Tema ETF Trust | 99,215 | 0 | 0 | 0 | For |
| John Hancock | 87,503 | 0 | 0 | 0 | For |
| Calamos | 72,844 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 70,417 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 67,441 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 61,722 | 0 | 0 | 0 | For |
| AQR | 60,815 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 60,789 | 0 | 0 | 0 | For |
| ProShares | 50,750 | 0 | 0 | 0 | For |
| TIAA | 47,790 | 0 | 0 | 0 | For |
| Northern Trust | 42,563 | 0 | 0 | 0 | For |
| JPMorgan | 31,802 | 0 | 0 | 0 | For |
| Pacific Life | 30,452 | 0 | 0 | 0 | For |
| Global X | 23,834 | 0 | 0 | 0 | For |
Showing the 25 largest of 59 asset managers. All 59 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 741,609,390 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | T. Rowe Price | 0.59% |
| 2 | Vanguard | 0.50% |
| 3 | Fidelity | 0.18% |
| 4 | Charles Schwab | 0.17% |
| 5 | Aberdeen | 0.16% |
| 6 | BlackRock | 0.10% |
| 7 | State Street | 0.03% |
| 8 | Lincoln Financial | 0.03% |
| 9 | Putnam | 0.02% |
| 10 | Equitable | 0.02% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | T. Rowe Price | 0.72% |
| 2 | Fidelity | 0.37% |
| 3 | PICTET ASSET MANAGEMENT SA | 0.31% |
| 4 | Charles Schwab | 0.17% |
| 5 | State Street | 0.17% |
| 6 | Aberdeen | 0.16% |
| 7 | BlackRock | 0.15% |
| 8 | ROCKLAND TRUST CO | 0.11% |
| 9 | Rock Springs Capital Management LP | 0.08% |
| 10 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 0.06% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Robert W. Duggan | 555,680,151 | 74.93% | Proxy statement (DEF 14A), table as of April 15, 2025 |
| Mahkam Zanganeh | 35,738,442 | 4.82% | Proxy statement (DEF 14A), table as of April 15, 2025 |
| Yu (Michelle) Xia | 31,523,530 | 4.25% | Proxy statement (DEF 14A), table as of April 15, 2025 |
| Vanguard Group | 11,640,507 | 1.57% | Form 13F, quarter ended March 31, 2025 |
| FMR (Fidelity) | 9,338,223 | 1.26% | Form 13F, quarter ended March 31, 2025 |
| BlackRock | 8,397,556 | 1.13% | Form 13F, quarter ended March 31, 2025 |
| T. Rowe Price | 6,557,804 | 0.88% | Form 13F, quarter ended March 31, 2025 |
| State Street | 4,851,388 | 0.65% | Form 13F, quarter ended March 31, 2025 |
| Geode Capital | 3,284,882 | 0.44% | Form 13F, quarter ended March 31, 2025 |
| Manmeet Soni | 3,020,242 | 0.41% | Proxy statement (DEF 14A), table as of April 15, 2025 |
Percentages above are of 741,609,390 shares outstanding, as reported by SUMMIT THERAPEUTICS INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At SUMMIT THERAPEUTICS INC.'s shareholder meeting held June 12, 2025, in the 2024-2025 proxy season, 227 asset managers reported votes on at least one of its 11 ballot items in their SEC Form N-PX filings, covering 2,643 separate fund positions. On the most widely held item on that ballot — Approval, by a non-binding advisory vote, of the compensation of our named executive officers. — FOR was 97% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: SUMMIT THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 17, 2025.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from SUMMIT THERAPEUTICS INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
SUMMIT THERAPEUTICS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Proxy Votes Now, “SUMMIT THERAPEUTICS (SMMT) 2025 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/summit-therapeutics-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.